InsidersTradesSigma
Follow the 제일약품 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 제일약품 has recorded 1 reports. Market capitalisation: €140.9bn. The latest transaction was reported on 30 April 2026 (Sale). Among the most active insiders: 한승수. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
제일약품 es una empresa surcoreana especializada en el sector de la salud y farmacéutico. Cotiza en la bolsa de valores XKRX.